I’ve said previously on another stock that the ASX is an amateur (to put it politely) when it comes to valuing stocks in the bio space; one only needs to do an analysis on NEU’s income runway for 2023 to know that the SP should be valued between $12-15 at the present time; the ASX will get it’s guidance from ACAD trading tonight.
When the ROW deal is announced things will really heat up.
IMHO.
I’ve said previously on another stock that the ASX is an amateur...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.00 |
Change
-0.020(0.15%) |
Mkt cap ! $1.660B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $3.920M | 302.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 1760 | $12.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.00 | 978 | 13 |
View Market Depth
| Last trade - 15.08pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |